XTX Topco Ltd Boosts Stock Holdings in Aflac Incorporated (NYSE:AFL)

XTX Topco Ltd boosted its position in Aflac Incorporated (NYSE:AFL) by 1,061.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 40,380 shares of the financial services provider’s stock after buying an additional 36,903 shares during the quarter. Aflac makes up about 0.3% of XTX Topco Ltd’s holdings, making the stock its 16th largest position. XTX Topco Ltd’s holdings in Aflac were worth $4,177,000 at the end of the most recent reporting period.

Other hedge funds have also recently made changes to their positions in the company. Private Trust Co. NA boosted its holdings in Aflac by 1.3% in the 4th quarter. Private Trust Co. NA now owns 7,643 shares of the financial services provider’s stock worth $791,000 after buying an additional 99 shares during the period. Phillips Wealth Planners LLC boosted its holdings in shares of Aflac by 1.5% in the fourth quarter. Phillips Wealth Planners LLC now owns 6,553 shares of the financial services provider’s stock worth $662,000 after acquiring an additional 100 shares during the period. Raleigh Capital Management Inc. grew its position in shares of Aflac by 23.2% in the fourth quarter. Raleigh Capital Management Inc. now owns 531 shares of the financial services provider’s stock valued at $55,000 after purchasing an additional 100 shares in the last quarter. TKG Advisors LLC raised its stake in shares of Aflac by 0.5% during the 4th quarter. TKG Advisors LLC now owns 21,255 shares of the financial services provider’s stock valued at $2,230,000 after purchasing an additional 103 shares during the period. Finally, Robertson Stephens Wealth Management LLC raised its stake in shares of Aflac by 1.6% during the 4th quarter. Robertson Stephens Wealth Management LLC now owns 6,960 shares of the financial services provider’s stock valued at $720,000 after purchasing an additional 107 shares during the period. 67.44% of the stock is currently owned by institutional investors.

Aflac Price Performance

AFL opened at $106.84 on Monday. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.08 and a current ratio of 0.10. The stock has a market capitalization of $58.31 billion, a PE ratio of 11.13, a price-to-earnings-growth ratio of 3.24 and a beta of 0.81. The stock’s 50 day moving average price is $106.34 and its 200-day moving average price is $107.41. Aflac Incorporated has a 52-week low of $79.69 and a 52-week high of $115.50.

Aflac (NYSE:AFL) last issued its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $1.56 EPS for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. On average, equities research analysts predict that Aflac Incorporated will post 6.88 EPS for the current year.

Insiders Place Their Bets

In related news, Director Charles D. Lake II sold 29,802 shares of the business’s stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $107.29, for a total transaction of $3,197,456.58. Following the sale, the director now owns 49,962 shares of the company’s stock, valued at $5,360,422.98. The trade was a 37.36 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Joseph L. Moskowitz sold 1,000 shares of Aflac stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $107.63, for a total transaction of $107,630.00. Following the transaction, the director now owns 25,393 shares of the company’s stock, valued at $2,733,048.59. The trade was a 3.79 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.90% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on AFL shares. Morgan Stanley decreased their price target on Aflac from $105.00 to $100.00 and set an “equal weight” rating on the stock in a research report on Thursday. Wells Fargo & Company cut their price objective on Aflac from $104.00 to $102.00 and set an “equal weight” rating for the company in a report on Wednesday, February 19th. Barclays decreased their price target on shares of Aflac from $98.00 to $95.00 and set an “underweight” rating on the stock in a research note on Friday, February 7th. StockNews.com raised shares of Aflac from a “sell” rating to a “hold” rating in a report on Friday, February 14th. Finally, Piper Sandler boosted their price target on shares of Aflac from $118.00 to $124.00 and gave the stock an “overweight” rating in a research note on Wednesday, April 2nd. Two equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, Aflac has an average rating of “Hold” and a consensus price target of $103.93.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.